CLINICAL_TRIALS
trial_result
· 2016-11-08
Clinical Trial Update: Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With Schizophrenia [Phase 2]
Summary
Phase 2 efficacy study evaluating Lu AE58054 as augmentation therapy in schizophrenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia, Cognition | Phase 2 | Status: COMPLETED